Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)

Japan flag Japan · Delayed Price · Currency is JPY
333.00
+5.00 (1.52%)
Mar 10, 2026, 12:55 PM JST
16.43%
Market Cap 11.41B
Revenue (ttm) 9.43B
Net Income (ttm) -222.00M
Shares Out 34.79M
EPS (ttm) -6.38
PE Ratio n/a
Forward PE n/a
Dividend 3.00 (0.88%)
Ex-Dividend Date Mar 30, 2026
Volume 30,400
Average Volume 153,980
Open 335.00
Previous Close 328.00
Day's Range 328.00 - 338.00
52-Week Range 270.00 - 371.00
Beta 0.57
RSI 52.66
Earnings Date May 15, 2026

About Wakamoto Pharmaceutical

Wakamoto Pharmaceutical Co.,Ltd. engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation, as well as Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its... [Read more]

Sector Healthcare
Founded 1929
Employees 403
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4512
Full Company Profile

Financial Performance

In fiscal year 2012, Wakamoto Pharmaceutical's revenue was 9.43 billion, a decrease of -2.45% compared to the previous year's 9.67 billion. Losses were -222.00 million, -47.76% less than in 2011.

Financial Statements

News

There is no news available yet.